Drug intelligence / Profile preview

[68Ga]Ga-TG3

Development stage
Preclinical
Lead developer
CHU de Bordeaux
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Peptides
Administration
Intravenous
01

Overview

[68Ga]Ga-TG3 (also referred to as [68Ga]Ga-tg3) is a radiolabeled neuropeptide-Y (NPY) analogue designed to target the neuropeptide-Y receptor type 5 (Y5R) for cancer imaging and potentially theranostic applications [1.1]. The peptide backbone, tg3 (DOTA-[cPP(1-7),NPY(19-32),Ala31,Aib32,Gln34]-hPP), is a highly selective Y5 receptor agonist [1.1]. When radiolabeled with the positron emitter gallium-68, it serves as a positron emission tomography (PET) imaging tracer [1.1]. Preclinical studies have demonstrated high affinity and selectivity for Y5R, with potential utility in imaging Y5R-overexpressing cancers such as breast and prostate cancers [1.1].

Other names
DOTA-[cPP(1-7),NPY(19-32),Ala31,Aib32,Gln34]-hPP[68Ga]Ga-DOTA-[cPP(1-7),NPY(19-32),Ala31,Aib32,Gln34]-hPP[68Ga]Ga-tg3
02

Targets

NPY5R (Neuropeptide Y receptor type 5)

Beyond the preview

Go deeper on [68Ga]Ga-TG3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [68Ga]Ga-TG3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call